Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Am J Clin Oncol. 2019 Jan;42(1):60–66. doi: 10.1097/COC.0000000000000477

Table 2.

Patient characteristics

Covariate Statistics Level No Treatment
N=2517
Resection Only
N=207
Radiation Only
N=1619
Chemotherapy Only
N=602
Combination of 2 or More
N=1024
Overall
N=5969
Age at BM N (%) 66–75 1122 (44.6) 123 (59.4) 921 (56.9) 414 (68.8) 689 (67.3) 3269 (54.8)
N (%) 76–85 1002 (39.8) 68 (32.9) 565 (34.9) 167 (27.7) 310 (30.3) 2112 (35.4)
N (%) 86+ 393 (15.6) 16 (7.7) 133 (8.2) 21 (3.5) 25 (2.4) 588 (9.9)
Race N (%) White 2119 (84.2) 180 (87) 1397 (86.3) 511 (84.9) 910 (88.9) 5117 (85.7)
N (%) Not White 398 (15.8) 27 (13) 222 (13.7) 91 (15.1) 114 (11.1) 852 (14.3)
Marital Status N (%) Married 1193 (47.4) 115 (55.6) 782 (48.3) 333 (55.3) 576 (56.3) 2999 (50.2)
N (%) Not Married 1324 (52.6) 92 (44.4) 837 (51.7) 269 (44.7) 448 (43.8) 2970 (49.8)
Location of Residence N (%) Metro 2243 (89.1) 191 (92.3) 1385 (85.5) 533 (88.5) 875 (85.4) 5227 (87.6)
N (%) Not Metro 274 (10.9) 16 (7.7) 234 (14.5) * * *
N (%) Missing 0 (0) 0 (0) 0 (0) * * *
Reason for Medicare enrollment N (%) Age 2330 (92.6) 195 (94.2) 1512 (93.4) 569 (94.5) 963 (94) 5569 (93.3)
N (%) Disability or ESRD 187 (7.4) 12 (5.8) 107 (6.6) 33 (5.5) 61 (6) 400 (6.7)
Comorbidity N (%) 0 1239 (49.2) 129 (62.3) 939 (58) 365 (60.6) 645 (63) 3317 (55.6)
N (%) 1 714 (28.4) 46 (22.2) 445 (27.5) 162 (26.9) 268 (26.2) 1635 (27.4)
N (%) 2+ 564 (22.4) 32 (15.5) 235 (14.5) 75 (12.5) 111 (10.8) 1017 (17)
Cancer Burden N (%) 1 2248 (89.3) 181 (87.4) 1463 (90.4) 543 (90.2) 919 (89.7) 5354 (89.7)
N (%) 2+ 269 (10.7) 26 (12.6) 156 (9.6) 59 (9.8) 105 (10.3) 615 (10.3)
Extracranial Metastasis N (%) No 935 (37.1) 82 (39.6) 176 (10.9) 17 (2.8) 76 (7.4) 1286 (21.5)
N (%) Yes 1582 (62.9) 125 (60.4) 1443 (89.1) 585 (97.2) 948 (92.6) 4683 (78.5)
Stage N (%) In situ / Localized 1388 (55.1) 115 (55.6) 620 (38.3) 182 (30.2) 382 (37.3) 2687 (45)
N (%) Regional 746 (29.6) 76 (36.7) 581 (35.9) 257 (42.7) 360 (35.2) 2020 (33.8)
N (%) Distant 329 (13.1) * 388 (24) 145 (24.1) 258 (25.2) *
N (%) Unknown 54 (2.1) * 30 (1.9) 18 (3) 24 (2.3) *
ER N (%) ER+ 1215 (48.3) 86 (41.5) 726 (44.8) 302 (50.2) 404 (39.5) 2733 (45.8)
N (%) ER− 307 (12.2) 36 (17.4) 417 (25.8) 131 (21.8) 365 (35.6) 1256 (21)
N (%) Unknown 995 (39.5) 85 (41.1) 476 (29.4) 169 (28.1) 255 (24.9) 1980 (33.2)
PR N (%) PR+ 981 (39) 69 (33.3) 554 (34.2) 228 (37.9) 288 (28.1) 2120 (35.5)
N (%) PR− 505 (20.1) 52 (25.1) 573 (35.4) 201 (33.4) 472 (46.1) 1803 (30.2)
N (%) Unknown 1031 (41) 86 (41.5) 492 (30.4) 173 (28.7) 264 (25.8) 2046 (34.3)
Year of BM Diagnosis N (%) 1992–1996 545 (21.7) 36 (17.4) 272 (16.8) 84 (14) 103 (10.1) 1040 (17.4)
N (%) 1997–2002 635 (25.2) 54 (26.1) 357 (22.1) 143 (23.8) 216 (21.1) 1405 (23.5)
N (%) 2003–2008 777 (30.9) 71 (34.3) 557 (34.4) 229 (38) 421 (41.1) 2055 (34.4)
N (%) 2009–2012 560 (22.2) 46 (22.2) 433 (26.7) 146 (24.3) 284 (27.7) 1469 (24.6)
AMC Service N (%) No 1500 (59.6) 119 (57.5) 1091 (67.4) 375 (62.3) 654 (63.9) 3739 (62.6)
N (%) Yes 1017 (40.4) 88 (42.5) 528 (32.6) 227 (37.7) 370 (36.1) 2230 (37.4)
Status N (%) Alive 492 (19.5) 52 (25.1) 90 (5.6) 56 (9.3) 60 (5.9) 750 (12.6)
N (%) Deceased 2025 (80.5) 155 (74.9) 1529 (94.4) 546 (90.7) 964 (94.1) 5219 (87.4)
Age at BM Mean 77.0 74.6 74.8 73.2 73.1 75.3
Median 76.3 73.7 73.5 72.2 72.0 74.1
Interval from BC to BM (years) Mean 6.5 7.3 4.9 5.6 5.0 5.7
Median 4.5 5.8 3.1 3.5 3.3 3.7
*

Suppressed because of small cell counts

Abbreviations: AMC, academic medical center; BC, breast cancer; BM, brain metastasis; ER, estrogen receptor; ESRD, end stage renal disease; PR, progesterone receptor.